Continuing the Suspension of Duty-Free De Minimis Treatment for All Countries
Record date: 2026-04-09
Executive Order 14388 of February 20, 2026 Continuing the Suspension of Duty-Free De Minimis Treatment for All Countries Republication [Editorial Note: Executive Order 14388 was originally published on pages 9433 through 9436 in the issue of Wednesday, February 25, 2026. In that publication, the document did not include the accompanying annex. The corrected document is republished in its entirety with the accompanying annex.] By the authority vested in me as President by the Constitution and the laws of the United States of America, including the International Emergency Economic Powers Act
What this record contains
- Federal Register document
- R1-2026-03829
- Publication date
- 2026-04-09
- Citation
- 91 FR 17839
- Issuing office
- Executive Office of the President
Official record excerpt
Executive Order 14388 of February 20, 2026 Continuing the Suspension of Duty-Free De Minimis Treatment for All Countries Republication [Editorial Note: Executive Order 14388 was originally published on pages 9433 through 9436 in the issue of Wednesday, February 25, 2026. In that publication, the document did not include the accompanying annex. The corrected document is republished in its entirety with the accompanying annex.] By the authority vested in me as President by the Constitution and the laws of the United States of America, including the International Emergency Economic Powers Act ( 50 U.S.C. 1701 et seq. ) (IEEPA), the National Emergencies Act ( 50 U.S.C. 1601 et seq. ), section 604 of the Trade Act of 1974, as amended ( 19 U.S.C. 2483 ), and section 301 of title 3, United States Code , it is hereby ordered: Section 1 . Background. In several Executive Orders, including Executive Order 14193 of February 1, 2025 (Imposing Duties To Address the Flow of Illicit Drugs Across Our Northern Border), as amended; Executive Order 14194 of February 1, 2025 (Imposing Duties To Address the Situation at Our Southern Border), as amended; Executive Order 14195 of February 1, 2025 (Imposing Duties To Address the Synthetic Opioid Supply Chain in the People's Republic of China), as amended; Executive Order 14257 of April 2, 2025 (Regulating Imports With a Reciprocal Tariff To Rectify Trade Practices That Contribute to Large and Persistent Annual United States Goods Trade Deficits), as amended; and Executive Order 14324 of July 30, 2025 (Suspending Duty-Free De Minimis Treatment for All Countries), I declared or described national emergencies with respect to unusual and extraordinary threats to the national security, foreign policy, or economy of the United States and took action to deal with those threats, including suspending duty-free de minimis treatment under 19 U.S.C. 1321(a)(2)(C) for certain imports. As relevant here, in section 3 of Executive Order 14324 , I set forth the duty rates applicable to shipments sent to the United States through the international postal network that would otherwise qualify for the de minimis exemption under 19 U.S.C. 1321(a)(2)(C) . These duty rates were based on the additional duty rates imposed by Executive Orders issued under IEEPA, including Executive Order 14193 , as amended; Executive Order 14194 , as amended; Executive Order 14195 , as amended; and Executive Order 14257 , as amended. In section 6 of Executive Order 14324 , I made clear that the suspension of, or continued suspension of, duty-free de minimis treatment, as detailed in Executive Order 14324 , shall not be affected if the additional duties imposed under Executive Order 14193 , as amended; Executive Order 14194 , as amended; Executive Order 14195 , as amended; or Executive Order 14257 , as amended, were held to be invalid. I also provided that—should such invalidation occur—duty-free de minimis treatment under 19 U.S.C. 1321(a)(2)(C) would be available for shipments sent through the international postal network only until I received a notification from the Secretary of Commerce (Secretary) that adequate systems were in place to fully and expeditiously process and collect duties applicable to such shipments. ( printed page 17840) Since the issuance of Executive Order 14324 , the conditions outlined in section 6 of Executive Order 14324 have occurred. Also since the issuance of Executive Order 14324 , the Secretary has notified me that adequate systems are now in place to collect certain duties applicable to shipments sent through the international postal network that would otherwise be eligible for duty-free de minimis treatment. I also have received additional information and recommendations from various senior officials regarding the suspension of duty-free de minimis treatment. After considering the information and recommendations these officials have provided to me, among other things, I have determined that it is still necessary and appropriate to suspend duty-free de minimis treatment under 19 U.S.C. 1321(a)(2)(C) , including for shipments sent through the international postal network. U.S. Customs and Border Protection (CBP) shall collect duties on shipments sent through the international postal network in accordance with Executive Order 14324 , as amended below. CBP shall also continue to take all appropriate action to collect all applicable duties, taxes, fees, exactions, and charges for shipments not sent
The excerpt is reproduced from the public federal record and may omit later sections, tables, signatures or attachments. Open the official source for the complete text.
Questions for accountability
- What legal authority does this immigration action cite?
- Which agencies or officials were directed to act?
- What measurable implementation, cost, deadline or later court action followed?
How to use this page
This is a source-record entry, not a truth-rating by itself. It preserves the action, date and original government publication so it can be connected to later claims, implementation records, court decisions, costs and measurable outcomes. Editorial claim reviews on this site use separate finding labels and explain the evidence for those findings.